ANTX
AN2 Therapeutics, Inc.
4.54
1 x 3.35
1 x 5.81
bid
ask
-
0.16
3.50%
11:23 AM
timesize
| Ytd | 297.85% | |
| 1y | 319.95% |
4.53
day range
4.78
1.00
52 week range
6.91
| Open | 4.71 | Prev Close | 4.70 | Low | 4.53 | High | 4.78 | Mkt Cap | 163.51M |
| Vol | 17.40K | Avg Vol | 331.05K | EPS | -1.10 | P/E | N/A | Forward P/E | -1.17 |
| Beta | -0.22 | Short Ratio | 0.82 | Inst. Own | 52.31% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 4.58 | 200-d Avg | 2.44 | 1yr Est | 2.67 |
| Income Statement | |||
| Operating Expenses | 10.55M | ||
| Research and Development Expense | 6.74M | ||
| Selling, General and Administrative Expense | 3.81M | ||
| Operating Income | -10.55M | ||
| Net Income | -10.03M | ||
| Net Income Common Stock | -10.03M | ||
| Net Income Common Stock (USD) | -10.03M | ||
| Consolidated Income | -10.03M | ||
| Earnings per Basic Share | -0.29 | ||
| Earnings per Basic Share (USD) | -0.29 | ||
| Earnings per Diluted Share | -0.29 | ||
| Earning Before Interest & Taxes (EBIT) | -10.03M | ||
| Earning Before Interest & Taxes (USD) | -10.03M | ||
| Weighted Average Shares | 34.06M | ||
| Weighted Average Shares Diluted | 34.06M | ||
| Balance Sheet | |||
| Cash and Equivalents | 53.49M | ||
| Cash and Equivalents (USD) | 53.49M | ||
| Investments | 31.80M | ||
| Investments Current | 31.80M | ||
| Current Assets | 87.49M | ||
| Total Assets | 87.49M | ||
| Current Liabilities | 5.56M | ||
| Total Liabilities | 5.73M | ||
| Accumulated Retained Earnings (Deficit) | -250.98M | ||
| Accumulated Other Comprehensive Income | -5.00K | ||
| Shareholders Equity | 81.76M | ||
| Shareholders Equity (USD) | 81.76M | ||
| Liabilities Non-Current | 170.00K | ||
| Trade and Non-Trade Payables | 2.62M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 37.33M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 33.55M | ||
| Issuance (Purchase) of Equity Shares | 37.33M | ||
| Net Cash Flow from Investing | 8.29M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.29M | ||
| Net Cash Flow from Operations | -12.07M | ||
| Share Based Compensation | 1.46M | ||